Cancer related deaths have declined in the US over the past decade due largely to improvement and compliance in screening for many types of cancer. The elucidation of cancer as a genetic disease led to numerous studies to evaluate the ability of mutations
in oncogenes, tumor suppressor genes, and loss of heterozygoisity as biomarkers for detecting cancer in biological fluids.

Gentron’s Response

We look into early cancer detection through a different approach. Our overall rationale is based upon the concept that we can detect cancer signals during several years of asymptomatic cancer growth, hence allowing a very early cancer diagnosis.    read more>>